Literature DB >> 24993463

What is new in the use of aminoglycosides in critically ill patients?

Dimitrios K Matthaiou1, Jan De Waele, George Dimopoulos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24993463     DOI： 10.1007/s00134-014-3376-7

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  15 in total

1.  Predictors of insufficient amikacin peak concentration in critically ill patients receiving a 25 mg/kg total body weight regimen.

Authors:  Etienne de Montmollin; Lila Bouadma; Nathalie Gault; Bruno Mourvillier; Eric Mariotte; Sarah Chemam; Laurent Massias; Emmanuelle Papy; Florence Tubach; Michel Wolff; Romain Sonneville
Journal:  Intensive Care Med       Date:  2014-04-01       Impact factor: 17.440

2.  Evaluating amikacin dosage regimens in intensive care unit patients: a pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulation.

Authors:  Hinojal Zazo; Ana Martín-Suárez; José M Lanao
Journal:  Int J Antimicrob Agents       Date:  2013-06-05       Impact factor: 5.283

3.  Infections caused by carbapenem-resistant Klebsiella pneumoniae among patients in intensive care units in Greece: a multi-centre study on clinical outcome and therapeutic options.

Authors:  F Kontopidou; H Giamarellou; P Katerelos; A Maragos; I Kioumis; E Trikka-Graphakos; C Valakis; H C Maltezou
Journal:  Clin Microbiol Infect       Date:  2013-08-30       Impact factor: 8.067

Review 4.  Combination therapy for treatment of infections with gram-negative bacteria.

Authors:  Pranita D Tamma; Sara E Cosgrove; Lisa L Maragakis
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

Review 5.  Aminoglycosides for life-threatening infections: a plea for an individualized approach using intensive therapeutic drug monitoring.

Authors:  J J De Waele; N De Neve
Journal:  Minerva Anestesiol       Date:  2013-12-11       Impact factor: 3.051

Review 6.  Pharmacokinetic issues for antibiotics in the critically ill patient.

Authors:  Jason A Roberts; Jeffrey Lipman
Journal:  Crit Care Med       Date:  2009-03       Impact factor: 7.598

7.  Pharmacokinetics of gentamicin in critically ill patients: pilot study evaluating the first dose.

Authors:  J Gonçalves-Pereira; A Martins; P Póvoa
Journal:  Clin Microbiol Infect       Date:  2009-10-14       Impact factor: 8.067

8.  Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock.

Authors:  Fabio Silvio Taccone; Pierre-François Laterre; Herbert Spapen; Thierry Dugernier; Isabelle Delattre; Brice Layeux; Daniel De Backer; Xavier Wittebole; Pierre Wallemacq; Jean-Louis Vincent; Frédérique Jacobs
Journal:  Crit Care       Date:  2010-04-06       Impact factor: 9.097

9.  Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009-2011).

Authors:  Helio S Sader; David J Farrell; Robert K Flamm; Ronald N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  2013-12-06       Impact factor: 2.803

10.  Risk factors for acute kidney injury in critically ill patients receiving high intravenous doses of colistin methanesulfonate and/or other nephrotoxic antibiotics: a retrospective cohort study.

Authors:  Monica Rocco; Luca Montini; Elisa Alessandri; Mario Venditti; Amalia Laderchi; Gennaro De Pascale; Giammarco Raponi; Michela Vitale; Paolo Pietropaoli; Massimo Antonelli
Journal:  Crit Care       Date:  2013-08-14       Impact factor: 9.097
View more
  5 in total

Review 1.  Focus on optimization of early antimicrobial therapy in ICU-acquired infections.

Authors:  Jean-François Timsit; José-Artur Paiva; Matteo Bassetti
Journal:  Intensive Care Med       Date:  2016-08-11       Impact factor: 17.440

2.  Focus on adequate antimicrobial treatment and de-escalation in the ICU.

Authors:  Dominique D Benoit; Gordon Doig; Jean-Francois Timsit
Journal:  Intensive Care Med       Date:  2016-09-29       Impact factor: 17.440

3.  Use of Gentamicin for Sepsis and Septic Shock in Anaesthesia-Intensive Care Unit: A Clinical Practice Evaluation.

Authors:  Cyril Pernod; Antoine Lamblin; Andrei Cividjian; Patrick Gerome; Wey Pierre-François
Journal:  Turk J Anaesthesiol Reanim       Date:  2019-12-26

4.  Propensity-based study of aminoglycoside nephrotoxicity in patients with severe sepsis or septic shock.

Authors:  W Picard; F Bazin; B Clouzeau; H-N Bui; M Soulat; E Guilhon; F Vargas; G Hilbert; S Bouchet; D Gruson; N Moore; A Boyer
Journal:  Antimicrob Agents Chemother       Date:  2014-10-06       Impact factor: 5.191

Review 5.  Year in review in Intensive Care Medicine 2014: III. Severe infections, septic shock, healthcare-associated infections, highly resistant bacteria, invasive fungal infections, severe viral infections, Ebola virus disease and paediatrics.

Authors:  Jean-François Timsit; Anders Perner; Jan Bakker; Matteo Bassetti; Dominique Benoit; Maurizio Cecconi; J Randall Curtis; Gordon S Doig; Margaret Herridge; Samir Jaber; Michael Joannidis; Laurent Papazian; Mark J Peters; Pierre Singer; Martin Smith; Marcio Soares; Antoni Torres; Antoine Vieillard-Baron; Giuseppe Citerio; Elie Azoulay
Journal:  Intensive Care Med       Date:  2015-03-26       Impact factor: 17.440
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.